A4LI H-SPAN Podcast
Episode 18 - Karl Pfleger
Jul 5, 2024
Karl Pfleger, a Super Angel in longevity, shares his journey from AI to biotech investing. Topics include advancements in aging biology, challenges in biotech startups, advocacy space growth, building a biotech database, exploring aging drugs, and rejuvenation therapies for longevity.
58:49
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Rejuvenation technologies prioritize helping older populations live healthier for longer periods.
- Targeting aging sub-pathologies as treatable diseases incentivizes advanced clinical trials.
Deep dives
Focus on Rejuvenation Therapies
Investing in rejuvenation technologies is prioritized over slowing aging due to the goal of helping a wider range of individuals, especially older populations, to live healthier for an extended period. Rejuvenation therapies offer the potential to reverse age-related molecular changes, restoring biological functions to a younger state. Stem cell secretions and atherosclerotic plaque reversal are additional areas of interest, aiming to rejuvenate tissues and alleviate age-linked health issues.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
